Perrigo Company PLC
NYSE:PRGO

Watchlist Manager
Perrigo Company PLC Logo
Perrigo Company PLC
NYSE:PRGO
Watchlist
Price: 14.74 USD 4.24% Market Closed
Market Cap: $2B

Net Margin

-1.2%
Current
Improving
by 0.9%
vs 3-y average of -2.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1.2%
=
Net Income
$-51.8m
/
Revenue
$4.3B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-1.2%
=
Net Income
$-51.8m
/
Revenue
$4.3B

Peer Comparison

Country Company Market Cap Net
Margin
IE
Perrigo Company PLC
NYSE:PRGO
2B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
48.8B ZAR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1.1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
564.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
284B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
294.9B USD
Loading...
CH
Novartis AG
SIX:NOVN
225.9B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
213.4B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
153.2B USD
Loading...

Market Distribution

Lower than 80% of companies in Ireland
Percentile
20th
Based on 314 companies
20th percentile
-1.2%
Low
-6 913.1% — 0%
Typical Range
0% — 10.2%
High
10.2% — 197.7%
Distribution Statistics
Ireland
Min -6 913.1%
30th Percentile 0%
Median 3.1%
70th Percentile 10.2%
Max 197.7%

Perrigo Company PLC
Glance View

Market Cap
2B USD
Industry
Pharmaceuticals

Perrigo Company PLC, a stalwart in the pharmaceutical and healthcare sectors, has carved a niche by specializing in over-the-counter (OTC) health and wellness products. This Dublin-based company traces its origins back to 1887, in Allegan, Michigan, where it began as a modest packager of home remedies. Over the decades, Perrigo has evolved into a global powerhouse that provides affordable and quality healthcare products, distributing them across various markets around the world. Its strategy hinges on delivering effective OTC solutions and a wide array of consumer self-care products, making it a familiar presence in households seeking reliable alternatives to more expensive brand-name pharmaceuticals. Perrigo's business model is centered on offering value to both consumers and retailers. By producing generic versions of well-known drugs, it captures a significant share of the market driven by cost-conscious customers. This approach also involves collaborating with retail giants to supply their private label OTC medications, a mutually beneficial arrangement that allows retailers to offer lower-cost alternatives under their own brands while maintaining healthy margins. Beyond just OTC medications, Perrigo has expanded its offerings to include nutritional products and topical solutions, further diversifying its portfolio and revenue streams. The company's consistent investment in innovation and keen attention to regulatory compliance underscore its commitment to quality and safety, attributes that resonate well in an industry guided by trust and efficacy.

PRGO Intrinsic Value
47.84 USD
Undervaluation 69%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-1.2%
=
Net Income
$-51.8m
/
Revenue
$4.3B
What is Perrigo Company PLC's current Net Margin?

The current Net Margin for Perrigo Company PLC is -1.2%, which is above its 3-year median of -2.1%.

How has Net Margin changed over time?

Over the last 3 years, Perrigo Company PLC’s Net Margin has increased from -2.4% to -1.2%. During this period, it reached a low of -4.2% on Mar 29, 2025 and a high of -0.1% on Sep 30, 2023.

Back to Top